Home
About
Team
News
Contact
Home
About
Team
News
Contact
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
January 23, 2017
by
Joel Drewry